… is also more aggressive and lethal, COPD patients stand to benefit the most from ICS treatment
[9, 10]. The limited evidence in favour of ICS chemoprevention for lung cancer … evidence, …

… In this chapter, we discuss the clinical evidence for the possible … reduce the risk of lung
cancer in COPD, more solid evidence is … Post-inhaled corticosteroid pulmonary tuberculosis and …

… shared risk factor for both COPD and lung cancer, evidence … ) and (iv) chemoprevention.
In MEDLINE and CENTRAL, all … against lung cancer, but this effect may only occur with more …

… evidence suggests that COPD and impaired lung function are associated with the occurrence
of … treatment to reduce incidence of lung cancer provides an additional incentive to manage …

… (ICS) are suggested for potential chemoprevention of lung cancer… Nevertheless, some find
the evidence sufficiently compelling to … Using a large cohort of >60 000 new users of COPD …

… Nevertheless, the proposed chemo-prevention effect of ICS … , found evidence of chronic Cpn
infection as well as COPD in ~… risk for the development of COPD as well as lung cancer [93]…

… for a chemopreventive effect on lung carcinogenesis in mice.… reports or evidence such
as additional laboratory and … pulmonary disease (COPD) also suggested a reduction in the …

… a protective effect against lung cancer in COPD patients. It could … More and more evidence
(35-37) has shown that EMT may … Inhaled corticosteroid normalizes some but not all airway …

… of inhaled corticosteroids among patients with COPD was … A priori, we stratified inhaled
corticosteroid use into two groups to ensure … for lung cancer pathogenesis and chemoprevention. …

… role in lung cancer prevention among female COPD patients. … The evidence suggests that
COPD is an independent risk … to have chemopreventive efficacy on mouse lung tumorigenesis …